National Institute of General Medical Sciences
Overview
The National Institute of General Medical Sciences (NIGMS) is one of the National Institutes of Health (NIH) in the United States. It primarily supports basic biomedical research that is not targeted to specific diseases, aiming to increase the understanding of life processes and lay the foundation for advances in disease diagnosis, treatment, and prevention. The institute funds research in fields like cell biology, genetics, pharmacology, and computational biology. NIGMS also provides leadership in training the next generation of scientists and increasing the diversity of the scientific workforce. It supports thousands of investigators and research grants across the U.S.
Portfolio Companies
54
Website
nigms.nih.govInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sinopia Biosciences, Inc. | Dec 2025 | Grant | Co-investor |
| Z Biotech, LLC | Aug 2025 | Grant | Lead |
| WellSIM BioMedical Technologies Inc. | Apr 2025 | Grant | Co-investor |
| Sonoran Biosciences | Jan 2025 | Grant | Lead |
| Z Biotech, LLC | Dec 2024 | Grant | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.